184 related articles for article (PubMed ID: 25948798)
1. [Role of tissue markers on diagnosis, prognosis and monitoring of prostate cancer].
Mora MJ
Arch Esp Urol; 2015 Apr; 68(3):250-66. PubMed ID: 25948798
[TBL] [Abstract][Full Text] [Related]
2. The role of genetic markers in the management of prostate cancer.
Choudhury AD; Eeles R; Freedland SJ; Isaacs WB; Pomerantz MM; Schalken JA; Tammela TL; Visakorpi T
Eur Urol; 2012 Oct; 62(4):577-87. PubMed ID: 22695242
[TBL] [Abstract][Full Text] [Related]
3. Genomic Markers in Prostate Cancer Decision Making.
Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP
Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398
[TBL] [Abstract][Full Text] [Related]
4. New and Emerging Diagnostic and Prognostic Immunohistochemical Biomarkers in Prostate Pathology.
Giannico GA; Arnold SA; Gellert LL; Hameed O
Adv Anat Pathol; 2017 Jan; 24(1):35-44. PubMed ID: 27941540
[TBL] [Abstract][Full Text] [Related]
5. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
6. New biomarkers in prostate cancer.
Crawford ED; Ventii K; Shore ND
Oncology (Williston Park); 2014 Feb; 28(2):135-42. PubMed ID: 24701701
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review.
van den Bergh RC; Ahmed HU; Bangma CH; Cooperberg MR; Villers A; Parker CC
Eur Urol; 2014 Jun; 65(6):1023-31. PubMed ID: 24491309
[TBL] [Abstract][Full Text] [Related]
9. From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer.
Hori S; Blanchet JS; McLoughlin J
BJU Int; 2013 Oct; 112(6):717-28. PubMed ID: 22759214
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for early prostate cancer detection.
Margreiter M; Stangelberger A; Valimberti E; Herwig R; Djavan B
Minerva Urol Nefrol; 2008 Mar; 60(1):51-60. PubMed ID: 18427435
[TBL] [Abstract][Full Text] [Related]
11. The role of proteomics in prostate cancer research: biomarker discovery and validation.
Pin E; Fredolini C; Petricoin EF
Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature.
Abrate A; Lughezzani G; Gadda GM; Lista G; Kinzikeeva E; Fossati N; Larcher A; Dell'Oglio P; Mistretta F; Buffi N; Guazzoni G; Lazzeri M
Korean J Urol; 2014 Jul; 55(7):436-45. PubMed ID: 25045441
[TBL] [Abstract][Full Text] [Related]
13. NMR-based metabolomics studies of human prostate cancer tissue.
Lima AR; Pinto J; Bastos ML; Carvalho M; Guedes de Pinho P
Metabolomics; 2018 Jun; 14(7):88. PubMed ID: 30830350
[TBL] [Abstract][Full Text] [Related]
14. Emerging biomarkers for the diagnosis and prognosis of prostate cancer.
Sardana G; Dowell B; Diamandis EP
Clin Chem; 2008 Dec; 54(12):1951-60. PubMed ID: 18927246
[TBL] [Abstract][Full Text] [Related]
15. Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes.
Cooperberg MR; Cowan JE; Lindquist KJ; Kobayashi Y; Simko JP; Bengtsson H; Singh K; Ngo V; Avila A; Newcomb LF; Tretriakova M; Lin DW; Stone S; Carroll PR; Paris PL
Eur Urol; 2021 Jan; 79(1):141-149. PubMed ID: 33148472
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen and other serum and urine markers in prostate cancer.
Stephan C; Ralla B; Jung K
Biochim Biophys Acta; 2014 Aug; 1846(1):99-112. PubMed ID: 24727384
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in prostate cancer: what's new?
Sartori DA; Chan DW
Curr Opin Oncol; 2014 May; 26(3):259-64. PubMed ID: 24626128
[TBL] [Abstract][Full Text] [Related]
18. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
19. Novel Diagnostic Biomarkers of Prostate Cancer: An Update.
Anceschi U; Tuderti G; Lugnani F; Biava PM; Malossini G; Luciani L; Cai T; Marsiliani D; Filianoti A; Mattevi D; Costantini M; Misuraca L; Simone G
Curr Med Chem; 2019; 26(6):1045-1058. PubMed ID: 30215331
[TBL] [Abstract][Full Text] [Related]
20. New markers in prostate cancer: Genomics.
Fuessel S; Wirth MP
Arch Esp Urol; 2019 Mar; 72(2):116-125. PubMed ID: 30855012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
